Lupin fell 1.65% to Rs 850 at 9:20 IST on BSE after the US drug regulator stated that the drug major's Pithampur facility may be subject to regulatory or administrative action.
Sales rise 500.00% to Rs 0.72 crore
Sales decline 18.03% to Rs 2.91 crore
Sales rise 3.35% to Rs 191.47 crore
Sales rise 2.44% to Rs 44.96 crore
Total Operating Income rise 64.91% to Rs 876.85 crore
Sales rise 33.25% to Rs 27.17 crore
Sales rise 3.78% to Rs 27.71 crore
Sales rise 167.43% to Rs 273.13 crore
Sales rise 15.88% to Rs 383.05 crore
Sales rise 3.02% to Rs 39.87 crore
Sales decline 22.88% to Rs 195.47 crore
Sales rise 8.23% to Rs 3849.63 crore
Sales rise 111.56% to Rs 1791.16 crore
Sales rise 5.16% to Rs 1775.46 crore
Sales rise 9.39% to Rs 2638.34 crore
Sales decline 5.61% to Rs 8.42 crore
Sales decline 43.75% to Rs 0.27 crore
Sales decline 19.73% to Rs 407.73 crore